Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0018270,
umls-concept:C0023418,
umls-concept:C0039194,
umls-concept:C0087111,
umls-concept:C0205470,
umls-concept:C0332325,
umls-concept:C0427526,
umls-concept:C0439097,
umls-concept:C1515655,
umls-concept:C1533148,
umls-concept:C1533691,
umls-concept:C1547348,
umls-concept:C1552644,
umls-concept:C1553423,
umls-concept:C1705241,
umls-concept:C1823153,
umls-concept:C1948023,
umls-concept:C2349976,
umls-concept:C2603343
|
pubmed:issue |
11
|
pubmed:dateCreated |
1992-12-22
|
pubmed:abstractText |
Leukemic T cells from patient BU (WBC 22,000/microliter) resembled morphologically large granular lymphocytes, and expressed a V delta 1-encoded gamma delta T-cell receptor (TCR) on their surface. Upon in vitro activation with various mitogens, IL-2-dependent V delta 1+ cell lines were only obtained if V delta 1+ cells had been positively selected on a cell sorter before culture. However, even under these conditions, the V delta 1+ IL-2-dependent cell lines showed a TCR beta and gamma gene-rearrangement different from that of the freshly isolated leukemic cell population, indicating that they were not derived from the leukemic clone. Thus, known T-cell growth factors (IL-2, IL-4, IL-7) in concert with mitogenic signals failed to induce in vitro proliferation of the V delta 1+ leukemic clone. Interestingly, the patient responded to treatment with interferon-alpha 2c (daily dose of 10(6) I.U.). After 2 1/2 years of continuous interferon treatment, the patient is in partial remission with WBC around 8000/microliter.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0145-2126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1087-95
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1434745-Adult,
pubmed-meshheading:1434745-Cell Division,
pubmed-meshheading:1434745-Female,
pubmed-meshheading:1434745-Gene Rearrangement, T-Lymphocyte,
pubmed-meshheading:1434745-Humans,
pubmed-meshheading:1434745-Interferon-alpha,
pubmed-meshheading:1434745-Leukemia, Lymphoid,
pubmed-meshheading:1434745-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:1434745-T-Lymphocyte Subsets,
pubmed-meshheading:1434745-T-Lymphocytes
|
pubmed:year |
1992
|
pubmed:articleTitle |
Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo.
|
pubmed:affiliation |
Institute of Immunology, University of Heidelberg, München, Germany.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|